by Sam Eskandari | Apr 19, 2018 | News
VANCOUVER, British Columbia, April 18, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that Dr. Michael K. Pugsley PhD, FBPhS, DSP, a consultant in safety pharmacology, has joined its advisory...
by Sam Eskandari | Apr 16, 2018 | News
3 Carbon is in the business of designing cannabis extraction facilities and utilizing its own proprietary extraction methods. VANCOUVER, British Columbia, April 16, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is...
by Sam Eskandari | Mar 22, 2018 | News
March 21, 2018, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce the Company has completed the 100% takeover of its research arm, Cannevert Therapeutics Ltd. (“CTL”). As previously...
by Sam Eskandari | Mar 15, 2018 | News
VANCOUVER, British Columbia, March 15, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announce that Justin Kausel has joined the Company as Director of Business Development. Justin will report to Dr....
by Sam Eskandari | Mar 8, 2018 | News
VANCOUVER, British Columbia, March 08, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announce the signing of a non-binding Letter of Intent (“LOI”) with 3 Carbon Extractions Inc. (“Carbon”). It...
by Sam Eskandari | Feb 28, 2018 | News
VANCOUVER, British Columbia, Feb. 28, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered into a Memorandum of Understanding (“MoU”) with BioCan Technologies Inc. (“BioCan”) of...
